Principia Wealth Advisory »

4d Molecular Therapeutics In shares owned by Principia Wealth Advisory

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Principia Wealth Advisory from 13F filings

Historical chart of Principia Wealth Advisory investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Principia Wealth Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Principia Wealth Advisory

Quarter filed Position value Share count Share price at filing
2025-12-31 $403k 54k 7.50

More positions owned by Principia Wealth Advisory

Invesco Nasdaq 100 Etf Etf (QQQM)
Invesco Qqq Trust Series I Etf (QQQ)
Eyepoint Stock (EYPT)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Bny Mellon Us Large Cap Core Equity Etf Etf (BKLC)
State Street Spdr Portfolio S&p 1500 Composite Stock Market Etf Etf (SPTM)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Vanguard Intermediate-term Corporate Bond Etf Etf (VCIT)
Vanguard Ftse All-world Ex-us Index Fund Etf (VEU)
Ishares Gold Trust Etf (IAU)
Schwab High Yield Bond Etf Etf (SCYB)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Schwab 1000 Index Etf (SCHK)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
San Juan Basin Rty Tr Unit Ben Int Stock (SJT)

View all positions for Principia Wealth Advisory

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In